###begin article-title 0
###xml 37 40 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 58 61 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Distinct Genetic Loci Control Plasma HIV-RNA and Cellular HIV-DNA Levels in HIV-1 Infection: The ANRS Genome Wide Association 01 Study
###end article-title 0
###begin p 1
These authors also contributed equally to this work.
###end p 1
###begin p 2
Conceived and designed the experiments: WC LM CR PD JFD PB IT. Performed the experiments: WC MLC VAF SLC LDdS. Analyzed the data: CD LM CR CG OL JFD PB IT. Contributed reagents/materials/analysis tools: CD WC CG MLC OL VAF SLC CD FB JFD IT. Wrote the paper: CD LM CR PB IT.
###end p 2
###begin p 3
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 214 219 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 305 308 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 326 329 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 384 387 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 712 715 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 759 762 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 790 793 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1075 1078 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1095 1098 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1180 1183 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load. We performed a Genome Wide Association study in a cohort of 605 HIV-1-infected seroconverters for detection of novel genetic factors that influence plasma HIV-RNA and cellular HIV-DNA levels. Most of the SNPs strongly associated with HIV-RNA levels were localised in the 6p21 major histocompatibility complex (MHC) region and were in the vicinity of class I and III genes. Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers. Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene). Our data provide evidence that the MHC controls both HIV replication and HIV reservoir. They also indicate that two additional genomic loci may influence the HIV reservoir.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Ioannidis1">[1]</xref>
###xml 325 328 325 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Kaslow1">[2]</xref>
###xml 330 333 330 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Gao1">[3]</xref>
###xml 563 566 563 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Fellay1">[4]</xref>
###xml 102 107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 310 313 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 494 499 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 549 554 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 679 682 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 930 933 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 981 986 <span type="species:ncbi:9606">human</span>
In the past ten years, candidate gene approaches were used to investigate host genetic variability in HIV-1 disease. Chemokine receptors such as CCR5 and CCR2 [1] and Major Histocompatibility Complex (MHC) class I genetic variation have been definitively associated with either clinical disease progression or HIV-RNA levels [2], [3]. Recent advances in large-scale genotyping technologies enabled genome-wide association (GWA) strategies for detection of novel genetic variants that influence HIV-1 disease. In this respect, the first GWA study in HIV-1 disease [4] identified three Single Nucleotide Polymorphisms (SNPs): two of them, linked with the ability to control plasma HIV-RNA levels, were located within the MHC region (rs2395029 within HCP5 gene and rs9264942 near HLA-C), while a third SNP (rs9261174), located near ZNRD1, was only associated with disease progression. These data suggest that disease progression and HIV-RNA might be controlled by several loci of the human genome.
###end p 5
###begin p 6
###xml 213 216 213 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Mellors1">[5]</xref>
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Mellors2">[7]</xref>
###xml 431 434 431 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Rouzioux1">[8]</xref>
###xml 436 439 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Kostrikis1">[9]</xref>
###xml 1031 1035 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Brass1">[10]</xref>
###xml 7 10 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 100 103 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 199 202 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 222 225 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 323 326 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 441 444 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 453 456 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 499 504 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 530 533 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 710 713 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 749 752 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 864 867 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 908 911 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Plasma HIV-RNA levels differ largely between patients. This is the best known virological marker of HIV disease progression; its predictive value was proven at different points of the time course of HIV infection [5]-[7]. HIV-DNA levels in peripheral blood monononuclear cells (PBMC) is another major predictive marker for HIV disease progression representing a phenotype not yet studied in either candidate gene or GWA approaches [8], [9]. HIV-DNA and HIV-RNA levels measure two different forms of HIV-1. It is not clear whether HIV-DNA levels measure only the viral reservoir. Indeed both phenotypes can be determined accurately and, even though they are correlated, they are distinct predictive factors for HIV disease progression. Indeed plasma HIV-RNA is a composite marker reflecting viral fitness, replicative capacity and host control, while intracellular HIV-DNA levels reflect the establishment of HIV reservoirs and, thereof, the effect of numerous host proteins that may interact with the intracellular viral lifecycle [10].
###end p 6
###begin p 7
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Desquilbet1">[11]</xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Benjamini1">[12]</xref>
###xml 52 55 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 86 89 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 136 139 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 159 162 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 264 269 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 383 386 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 483 488 <span type="species:ncbi:9606">Human</span>
###xml 624 627 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We hypothesized that genetic variants that regulate HIV-DNA metabolism, in particular HIV latency, are different than those involved in HIV-RNA metabolism and HIV replication. For this purpose, we conducted a GWA study in the large ANRS PRIMO cohort of unselected HIV-1 seroconverters (observed median time since infection: 46 days) for identifying SNPs associated with early plasma HIV-RNA levels[11]. All 605 Caucasian subjects of this cohort were genotyped using Illumina Sentrix Human Hap300 Beadchip containing 317,139 tagging SNPs. We selected genetic variants having a high likelihood of being associated with plasma HIV-RNA levels for a false discovery rate (FDR)[12] of 25%.
###end p 7
###begin p 8
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Lambotte1">[13]</xref>
###xml 66 71 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 217 220 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 258 266 <span type="species:ncbi:9606">patients</span>
###xml 322 327 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
###xml 415 418 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 517 520 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 559 562 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 718 721 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 746 754 <span type="species:ncbi:9606">patients</span>
###xml 881 884 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In order to provide additional evidence to support these selected HIV-1 disease-related SNPs, we compared their allelic frequencies between this reference population (PRIMO) and an independent population of long-term HIV controllers[13]. The latter group of patients represents less than 0.5% of the general population of HIV-1 infected patients, and reflects an extreme phenotype compared to the PRIMO population. HIV controllers exhibit sustained spontaneous control of viral replication after at least 10 years of HIV infection (observed median time since HIV diagnosis 18 years). We hypothesized that true positive genetic variants obtained from the GWA will exhibit enrichment for protective alleles in long-term HIV controllers compared to patients from the PRIMO population. We also studied for the first time association signals for another viral phenotype, i.e., cellular HIV-DNA levels.
###end p 8
###begin p 9
###xml 58 61 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 227 230 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 318 326 <span type="species:ncbi:9606">patients</span>
###xml 443 446 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 463 466 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 501 504 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Taken together, our data redefine the regions controlling HIV-RNA within the MHC locus and indicate an independent effect of SNPs located nearby not only class I but also class III genes. Some of these SNPs are associated with HIV-RNA levels from primary infection and early seroconversion and are over-represented in patients showing long-term spontaneous control. Most importantly, our data provide evidence that the MHC locus controls both HIV replication and HIV-DNA levels while early control of HIV-DNA levels may be under the control of two additional genomic loci.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 15 19 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
GWA and plasma HIV1-RNA levels
###end title 11
###begin p 12
###xml 273 275 273 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003907-g001">Figure 1</xref>
###xml 144 147 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 319 327 <span type="species:ncbi:9606">patients</span>
A total of 308,222 SNPs on the autosomal chromosomes passed the quality-control filters. We tested for association of genotype and early plasma HIV-RNA levels using a linear regression model assuming an additive genetic effect with adjustment for gender. The calculated log10 P-values for the SNPs genotyped in the 605 patients from the PRIMO cohort are plotted in Figure 1.
###end p 12
###begin title 13
###xml 47 50 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Genome wide association (GWA) study for plasma HIV-RNA levels in the ANRS PRIMO cohort.
###end title 13
###begin p 14
###xml 12 14 12 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
Negative log10 (P)-values for the score test for genome-wide association across the genome ordered from 1pter to 22qter. Adjacent chromosomes are shown in light blue and dark blue. The spacing between SNPs does not reflect actual physical distances. The false discovery rate was calculated based on a stratified approach (by chromosome) leading to chromosome-specific thresholds.
###end p 14
###begin p 15
###xml 100 107 100 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t001">Table 1</xref>
###xml 673 674 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 890 891 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 916 917 916 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1018 1021 1018 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Fellay1">[4]</xref>
###xml 1137 1138 1137 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 32 35 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The SNPs associated with plasma HIV-RNA levels and selected for a FDR threshold of 25% are shown in Table 1; 15 SNPs were located on Chromosome 6, 3 each in chromosomes 12 and 16, and one on Chromosome 4. Among the 15 SNPs located in Chromosome 6, twelve were clustered within the 6p21 region harbouring the MHC (from 312 kb to 321 kb). The strongest association signal was observed for the rs10484554 SNP, which is located upstream from HLA-C. The rs10484554(T) protective allele had frequency of 0.128 in our population. The second highest association signal was observed for the rs2523619 SNP which lies within the HLA-B gene which is in strong linkage disequilibrium (r2 = 0.57) with the rs10484554 SNP. The third highest association signal obtained in the presented study was for the rs2395029 which lies within the class I gene HCP5 with weak linkage disequilibrium with rs10484554 (r2 = 0.13) and rs2523619 (r2 = 0.07). This association signal for rs2395029 replicates the result previously reported from CHAVI [4]. Another three HLA-C neighbouring SNPs (rs130065, rs3130467 and rs3130473) showing strong linkage disequilibrium (r2>0.5) and significant effects on viral load were among the top signals.
###end p 15
###begin title 16
###xml 71 74 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 101 106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The list of the most significant SNPs (FDR<25%) associated with plasma HIV-RNA levels during primary HIV-1 infection.
###end title 16
###begin p 17
###xml 49 52 49 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNP</bold>
###xml 71 74 71 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chr</bold>
###xml 94 102 94 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Position</bold>
###xml 172 186 172 186 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRIMO Q-values</bold>
###xml 276 290 276 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRIMO P-values</bold>
###xml 380 384 380 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Beta</bold>
###xml 468 482 468 482 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHAVI P-values</bold>
###xml 531 541 531 541 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CHAVI rank</bold>
###xml 765 767 765 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MA</bold>
###xml 818 826 818 826 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-values</bold>
###xml 933 936 933 936 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIC</bold>
###xml 141 146 <span type="species:ncbi:9606">Human</span>
###xml 247 250 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 351 354 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 907 910 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 923 931 <span type="species:ncbi:9606">patients</span>
###xml 933 936 <span type="species:ncbi:9606">HIC</span>
###xml 1030 1033 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1064 1067 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The following information is given for each SNP: SNP is the rs number; Chr is the chromosome; Position is the position along the chromosome (Human Genome NCBI Build 35.1); PRIMO Q-values are the Q-values for the genome-wide association study with HIV-RNA in the Primo cohort; PRIMO P-values are the P-values for the genome-wide association study with HIV-RNA in the Primo cohort; Beta is the slope parameter (allele indicated in bracket is used as a reference group); CHAVI P-values are the P-values obtained from the CHAVI study; CHAVI rank is the rank of the p-values (obtained from the CHAVI study) according to the Illumina 317K whole-genome single-nucleotide polymorphism arrays. The rank assigned to tied values is calculated by taking the mean of the ranks. MA is the minor allele in the HapMap CEU population; P-values are the P-values for the comparison of allele frequencies between the PRIMO and HIV controllers patients (HIC). The four major SNPs (printed in bold) are those being significantly associated with plasma HIV-RNA and showing enrichment in HIV-controllers for protective allelic variants.
###end p 17
###begin p 18
NA = Not Available (SNP discarded in the Chavi study).
###end p 18
###begin p 19
###xml 188 195 188 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t001">Table 1</xref>
###xml 241 243 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 483 485 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 507 514 507 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t001">Table 1</xref>
###xml 43 46 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 289 292 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 353 356 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 583 586 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 883 886 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
When comparing allelic frequencies between HIV-controllers and the PRIMO seroconverters, four SNPs located within the 6p21 (rs2395029, rs13199524, rs12198173 and rs3093662, are in bold in Table 1), showed highly significant differences (p<10-4) that correspond to a striking enrichment in HIV-controllers for protective allelic variants associated with HIV-RNA levels. We further designated them as major SNPs. Moreover, these four major SNPs showed highly significant p values (p<10-7) in the CHAVI study (Table 1). It should be noted that our study on the PRIMO cohort used plasma HIV-RNA levels measured at the time of primary infection, while the CHAVI study used viral loads measured during the plateau phase (6 to 18 months following seroconversion). Overall these results support the idea that these major SNPs have an effect on viral load throughout the whole time course of HIV disease.
###end p 19
###begin p 20
###xml 60 67 60 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t001">Table 1</xref>
###xml 104 113 104 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003907-g002">Figures 2</xref>
###xml 119 128 119 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003907.s001">Figure S1</xref>
###xml 133 142 133 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003907.s002">Figure S2</xref>
###xml 294 302 294 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003907-g001">Figure 1</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003907-g002">2</xref>
The extent of linkage disequilibrium between selected SNPs (Table 1) lying in the 6p21 area is shown in Figures 2, and Figure S1 and Figure S2. The genomic region flanked by these SNPs contains both MHC class I and class III genes and extends from the PSORS1C1 gene to TNXB gene. Supplementary Figure 1 and 2 display the linkage disequilibrium data matrix (based on HapMap CEU data) and the genes located witin this 6p21 region (from 312 kb to 321 kb).
###end p 20
###begin title 21
Location of the twelve selected SNPs in the MHC region (6p21) and linkage disequilibrium plot.
###end title 21
###begin p 22
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Upper box shows an ideogram depicting chromosome 6 and the annotated region (transparent yellow rectangle). Lower box shows the linkage disequilibrium data matrix calculated from the European HapMap population. The colour intensity of each box is proportional to the strength of the LD property (r2) for the marker pair.
###end p 22
###begin p 23
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003907-g002">Figure 2</xref>
###xml 177 184 177 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t001">Table 1</xref>
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Fellay1">[4]</xref>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 682 683 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 869 876 869 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Bristow1">[14,14]</xref>
###xml 1341 1345 1341 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Rupert1">[15]</xref>
###xml 950 955 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1534 1537 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Among the class I genes, only HLA-C and HLA-B genes are adjacent to SNPs associated with the control of plasma viral load (Figure 2). It should be noted that neither the PRIMO (Table 1) nor the CHAVI studies[4] provide evidence for association signals with HLA class II. Among the major SNPs, the rs2395029 is in moderate linkage disequilibrium (r2 = 0.21) with the rs3093662 SNP which lies within the Tumor Necrosis Factor (TNF) gene. The rs12198173 and rs13199524 SNPs showed moderate linkage disequilibrium with SNP rs2395029 as well as with all the other SNPs in the class I MHC region. Finally the rs12198173 and rs13199524 SNPs are in nearly complete linkage disequilibrium (r2 = 0.97), are both located in the class III region of MHC and both lie within introns of the TNXB gene. Although mutations in the TNXB gene are responsible for the Ehlers-Danlos Syndrome[14,14], it is unlikely that this gene is responsible for the observed effect in HIV-1 plasma viral load. Other neighbouring genes, particularly C4A and C4B (which show different types of polymorphisms such as duplications, gene recombinations, insertions, and SNPs inducing the appearance of premature stop codons) are located in the immediate telomeric side of TNXB and linked both to autoimmune and infectious diseases and are excellent candidate genes for this effect [15]. These results provide evidence that the region encompassing the HCP5 and MIC genes as well as the class III region encompassing TNXB and C4 genes region both contribute to the control of HIV-RNA levels.
###end p 23
###begin p 24
###xml 100 108 100 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003907-g003">Figure 3</xref>
###xml 650 652 650 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 14 17 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
###xml 180 183 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 240 248 <span type="species:ncbi:9606">patients</span>
###xml 352 355 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 548 556 <span type="species:ncbi:9606">patients</span>
###xml 662 665 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 792 800 <span type="species:ncbi:9606">patients</span>
###xml 907 915 <span type="species:ncbi:9606">patients</span>
###xml 998 1001 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Box plots for HIV-RNA levels measured during primary infection for the four major SNPs are shown in Figure 3. In patients homozygotes for the rs2395029(T) allele, the median value HIV-RNA was 5.09 (range: 4.48-5.70) whereas in heterozygous patients, the median was 4.20 (range: 3.25-5.09), illustrating that the minor allele G is associated with lower HIV-RNA levels. A similar trend for the minor allele G was observed for the rs3093662. Despite a minor allelic frequency of 0.083 (rs12198173) and 0.080 (rs13199524), with few observed homozygote patients for the protective alleles (A for rs12198173, T for rs13199524), a strong reduction (2.35 log10) for the HIV-RNA median level was observed. Both SNPs (rs12198173 and rs13199524) were located within the TNXB gene but the two homozygote patients also carried one favourable HLA allele such as HLA-B27 or HLA-B57. It should be noted that the homozygote patients for these protective alleles (rs12198173(A), rs13199524(T)) account for 4% of the HIV controllers versus 0.3% of the PRIMO seroconverters.
###end p 24
###begin title 25
###xml 13 16 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Boxplots for HIV-RNA levels in the PRIMO cohort for four major SNPs.
###end title 25
###begin p 26
###xml 7 10 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Plasma HIV-RNA level is highly correlated with the rs2395029 (HCP5), rs3093662 (TNF), rs13199524 and rs12198173 (TNXB) genotypes.
###end p 26
###begin p 27
###xml 185 192 185 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t001">Table 1</xref>
###xml 325 327 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-White1">[16]</xref>
###xml 901 905 901 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Suske1">[17]</xref>
###xml 907 911 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Turner1">[18]</xref>
###xml 1104 1108 1104 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Dominguez1">[19]</xref>
###xml 1110 1114 1110 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Prezant1">[20]</xref>
###xml 124 127 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 161 164 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 388 391 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Another important result of this study was the strong association of the rs11725412 SNP located on chromosome 4 with plasma HIV-RNA levels both in the PRIMO and HIV controller cohorts (Table 1). Although we cannot exclude that this finding represents a false positive signal, the p-value on the PRIMO analysis was low (p<6x10-6) and a significant (p<6.58x10-4) enrichment was observed in HIV-controllers. The rs11725412 SNP lies in an intergenic region in 4p14, its immediate functional neighbours are the TBC1D1 gene (telomeric) and the KLF3 gene (centromeric). TBC1D1, the founding member of a family of proteins sharing a 180 to 200 amino acid TBC domain, is presumed to have a role in regulating cell proliferation and differentiation[16]. The KLF3 protein has a characteristic zinc finger domain and is classified in the family of SP transcription factors but its precise function remains unknown[17], [18]. More distant genes in this region include several Toll like receptors (TLR1,6,10) and PTTG2 (a gene belonging to the securin family) that plays an important role in cell division and survival[19], [20].
###end p 27
###begin title 28
###xml 17 20 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
GWA and cellular HIV-DNA levels
###end title 28
###begin p 29
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Chun1">[21]</xref>
###xml 180 182 180 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 67 70 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 111 114 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 265 270 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 362 365 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 485 488 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 600 608 <span type="species:ncbi:9606">patients</span>
HIV-1 DNA levels in PBMCs are established at a very early stage of HIV infection and are representative of the HIV reservoir[21]. This marker showed a wide range (median = 3.30 log10 copies/millions PBMC; IQR = 0.76) in patients from the PRIMO cohort; in contrast, HIV-1 DNA levels were very low (median = 1.77 log copies/millions PBMC; IQR = 0.64) in long-term HIV-controllers. We hypothesized that this phenotype may be controlled by genomic regions different from those controlling HIV replication, particularly in phases of pre-integration or in provirus transcription that may be variable among patients.
###end p 29
###begin p 30
###xml 113 120 113 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t002">Table 2</xref>
###xml 427 434 427 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t002">Table 2</xref>
###xml 671 678 671 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t002">Table 2</xref>
###xml 890 897 890 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t001">Table 1</xref>
###xml 898 901 898 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Fellay1">[4]</xref>
###xml 1045 1049 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Xu1">[22]</xref>
###xml 1150 1154 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Jeang1">[23]</xref>
###xml 1214 1218 1214 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Hosono1">[24]</xref>
###xml 1401 1405 1401 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Bobardt1">[25]</xref>
###xml 1407 1411 1407 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Bobardt2">[26]</xref>
###xml 25 28 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 475 478 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 516 519 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 590 593 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 610 613 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 881 884 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1331 1334 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1359 1364 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1434 1437 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1491 1494 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1549 1552 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1673 1676 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1711 1719 <span type="species:ncbi:9606">patients</span>
The SNPs associated with HIV-DNA levels in the PRIMO cohort and selected for a FDR threshold of 25% are shown in Table 2. Among the 28 SNPs, 21 were located in the chromosome 6 (mainly in 6p21), 4 in chromosome 8, 1 in chromosome 17, 1 in chromosome 22 and 1 in chromosome 12. Some of these hits might represent false positives. However the four major SNPs (i.e., rs2395029, rs13199524, rs12198173 and rs3093662 are in bold in Table 2) previously found to be associated with HIV-RNA levels were also associated with HIV-DNA levels. This highlights the importance of the MHC region for both HIV replication and HIV reservoir. The first three SNPs (with q-value <2.3%, see Table 2) are located within three different chromosomes, specifically chromosomes 6, 17 and 8. The strongest association signal was observed for the rs2395029, one of the four major SNPs associated with plasma HIV-RNA (Table 1)[4]. The second highest association signal corresponds to rs6503919 SNP (chromosome 17). This SNP is found in an intergenic region flanked by DDX40[22] (which is a member of the DExH/D box family of ATP-dependent RNA helicases) (for a recent review see[23]), and YPEL2 (which is a putative zinc-binding protein gene)[24]. The rs2575735 SNP (chromosome 8) lies within the SDC2 gene which encodes for syndecan 2. Syndecan 2 is a trans HIV receptor which binds to HIV-1 gp120 through heparan sulfate chains[25], [26]. Keeping in mind that HIV controllers were selected on the basis of a specific HIV-RNA phenotype (<400 copies/ml after 10 years of known HIV infection), we observed no significant enrichment (p>0.1) for the protective alleles of rs6503919 and rs2575735 SNPs in HIV controllers compared to the PRIMO patients. Nevertheless, we cannot rule out the possibility that some of non-chromosome 6 hits may represent false positives.
###end p 30
###begin title 31
###xml 73 76 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 103 108 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The list of the most significant SNPs (FDR<25%) associated with cellular HIV-DNA levels during primary HIV-1 infection.
###end title 31
###begin p 32
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNP</bold>
###xml 22 25 22 25 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Chr</bold>
###xml 45 53 45 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Position</bold>
###xml 119 127 119 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Q-values</bold>
###xml 132 140 132 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-values</bold>
###xml 223 227 223 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Beta</bold>
###xml 311 313 311 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MA</bold>
###xml 364 372 364 372 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P-values</bold>
###xml 462 465 462 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIC</bold>
###xml 88 93 <span type="species:ncbi:9606">Human</span>
###xml 184 187 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 436 439 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 452 460 <span type="species:ncbi:9606">patients</span>
###xml 462 465 <span type="species:ncbi:9606">HIC</span>
SNP is the rs number; Chr is the chromosome; Position is position along the chromosome (Human Genome NCBI Build 35.1); Q-values and P-values for the genome-wide association study with HIV-DNA in the Primo cohort are shown; Beta is the slope parameter (allele indicated in bracket is used as a reference group); MA is the minor allele in the HapMap CEU population; P-values for the comparison of allele frequencies between the PRIMO and HIV controllers patients (HIC) are shown. The four major SNPs are in bold.
###end p 32
###begin p 33
###xml 136 143 136 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003907-t002">Table 2</xref>
###xml 158 166 158 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003907-g004">figure 4</xref>
###xml 575 577 575 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 677 679 677 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 753 755 753 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 955 959 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-NgoGiangHuong1">[27]</xref>
###xml 1036 1038 1036 1038 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 18 21 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 193 196 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 251 259 <span type="species:ncbi:9606">patients</span>
###xml 347 350 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 424 427 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 482 485 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 599 602 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 632 640 <span type="species:ncbi:9606">patients</span>
###xml 694 697 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 756 759 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1082 1090 <span type="species:ncbi:9606">patients</span>
###xml 1142 1145 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Box plots for the HIV-DNA levels in the PRIMO seroconverters for the first three SNPs (rs2395029, rs6503919, and rs2575735 as listed in Table 2) are shown in figure 4. The difference in median HIV-DNA levels between TT homozygotes and TG heterozygous patients for rs2395029 was -0.53, illustrating that the minor allele G is associated with lower HIV-DNA levels. A similar trend, i.e., a 0.36 difference in median values in HIV-DNA according to the genotype was also observed among HIV controllers. For the SNP rs6503919 located on chromosome 17, we observed both a -0.62 log10 difference in median HIV-DNA values between AA and GG patients in the PRIMO cohort, and a -0.45 log10 difference in HIV controllers according to the same genotype. A -0.62 log10 HIV-DNA difference is clinically highly significant since it can be compared to the effect obtained within the first year following antiretroviral treatment initiation with a classical triple therapy[27]. For the rs2575735 SNP in chromosome 8, we observed a reduction of -0.37 log10 between homozygotes AA and GG in the PRIMO patients. In contrast such a difference was not observed in HIV controllers. This result may imply a temporal effect which disappears over time.
###end p 33
###begin title 34
###xml 13 16 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Boxplots for HIV-DNA levels in the PRIMO cohort for the three major SNPs.
###end title 34
###begin p 35
###xml 9 12 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Cellular HIV-DNA level is highly correlated with the rs2395029 (HCP5), rs6503919 (intergenic DDX40 - YPEL2) and rs2575735 (SDC2) genotypes.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Hao1">[28]</xref>
###xml 459 465 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1115 1119 1115 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-deBakker1">[29]</xref>
###xml 1172 1175 1172 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Fellay1">[4]</xref>
###xml 1367 1371 1367 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Liu1">[30]</xref>
###xml 1780 1784 1780 1784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Magierowska1">[31]</xref>
###xml 1785 1789 1785 1789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Schneidewind1">[33]</xref>
###xml 2085 2089 2085 2089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Fodil1">[34]</xref>
###xml 2091 2095 2091 2095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Pellet1">[35]</xref>
###xml 2164 2168 2164 2168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Bauer1">[36]</xref>
###xml 2170 2174 2170 2174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Groh1">[37]</xref>
###xml 2238 2242 2238 2242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Mellors3">[38]</xref>
###xml 800 803 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1246 1249 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1506 1509 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1564 1567 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2054 2059 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2271 2274 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2284 2292 <span type="species:ncbi:9606">patients</span>
###xml 2453 2456 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2495 2498 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The present GWA study identified SNPs highly associated with early viral replication in the ANRS PRIMO cohort. Although in this study, we performed the genotyping using an Illumina 317K chip, and gains in terms of genetic coverage and transferability[28] could be obtained using more recent technologies it should be noted that the top SNPs associated with the control of viral load are located in the MHC locus in our and Fellay's study even that the Fellay et al. study considered a SNP-chip having higher genetic coverage (Illumina 550K SNP). Furthermore the definition of the viral phenotype is different between Fellay's study and this study; further explaining differences in the power of associations. Four of these SNPs exhibited a striking enrichment of their protective allele in long-term HIV controllers as compared to the unselected seroconverters from the PRIMO cohort. These four major SNPs are located in the 6p21 MHC in the vicinity of class I and III genes. The association signal observed for the rs2395029 SNP located in the HCP5 gene, which is in complete linkage disequilibrium with HLA-B*5701[29], replicates the previous report from the Chavi study[4]. Interestingly, the rs2395029*T allele which has a protective role in HIV infection was also recently shown to be associated with increased susceptibility to psoriasis and psoriatic arthritis[30]. One possible explanation for this MHC association signal is that variants of the classical HLA-B and HLA-C alleles optimally present HIV-derived peptides to CD8+ T-cells which, in turn, kill HIV-infected cells. The results of the present study make an additional contribution to reports in the literature regarding the importance of HLA-B27 and HLA-B57 in long-term non-progression and in viral load control[31]-[33]. Another possible explanation relates to other MHC-related gene variants in linkage disequilibrium with rs2395029 such as SNPs in the TNF gene. The fact that the MICB gene is flanked by rs2395029 and rs3093662 SNPs also suggests its contribution to the control of HIV-1 RNA. MICs are polymorphic[34], [35] and affect cell-mediated cytotoxicity through interaction with NKG2D[36], [37] while TNF variants affect numerous steps of the immune response[38]. It is, thus, possible that HIV-infected patients who have a particular set of the classical either HLA-B or HLA-C alleles associated with TNF and MIC protective alleles have an increased capability to control HIV replication during the time course of HIV disease.
###end p 37
###begin p 38
###xml 436 438 436 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 119 122 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 333 336 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
###xml 416 419 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 976 979 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In addition, the present study also highlights that some of the major SNPs located in the MHC region have an effect on HIV-RNA levels independently of SNP rs2395029. The two major SNPs rs12198173 and rs13199524, which are in nearly complete linkage disequilibrium, suggest that the class III region of MHC plays an important role in HIV replication. In homozygote patients for the minor allele of these SNPs, plasma HIV-RNA was 2.35 log10 lower than in patients with other genotypes. To the best of our knowledge, the present is the first study demonstrating that a rare genetic variant within the class III region of MHC is associated with important viral load changes, which are comparable to that obtained during the first weeks following multiple antiretroviral therapy initiation. Undoubtedly, such an efficient control of viral replication, both in terms of strength and duration, provides new insights into underlying mechanisms and may lead to novel methodologies for HIV vaccine design.
###end p 38
###begin p 39
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Carrington1">[39]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Martin1">[40]</xref>
###xml 764 768 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Liu1">[30]</xref>
###xml 197 200 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 392 395 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 834 837 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Moreover, the present study highlights the importance of SNPs adjacent to HLA-C such as the rs10484554 which was the most highly associated SNP in our study. HLA-C has a dual function: it presents HIV-derived peptides to T lymphocytes but also interacts with either activatory or inhibitory NK receptors. Unfortunately, very few studies have focused attention on the role of HLA-C alleles in HIV disease[39]. Recent reports[40] provided evidence of epistatic interactions between classical HLA-B alleles and KIR-receptor polymorphisms but again only the role of HLA-B allelic variants was studied. It is worth noting that the protective rs10484554*T allele was also recently shown to be associated with increased susceptibility to psoriasis and psoriatic arthritis[30]. These findings suggest that HLA-C deserves more attention as an HIV disease modifying gene.
###end p 39
###begin p 40
###xml 113 116 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 152 155 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 225 228 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 341 344 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 394 397 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 552 555 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The present one is the first study which explored the role of genetic variants on the early establishment of the HIV reservoir. Association signals for HIV-DNA levels revealed new genetic loci that may control early steps of HIV spreading. The four major SNPs associated with viral replication were also found to be strongly associated with HIV-DNA levels. The strongest association signal for HIV-DNA was again observed for the rs2395029 SNP located in the HCP5 gene suggesting that structural variants of MHC genes also play a very important role on HIV reservoir.
###end p 40
###begin p 41
###xml 660 664 660 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Jeang1">[23]</xref>
###xml 287 290 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 538 543 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Moreover, we found an association signal for the SNP rs6503919 in chromosome 17 which lies in an intergenic region flanked by the DDX40 and YPEL2 genes. One plausible explanation for this finding is that the Helicase DDX40 structural variants play an important role in the metabolism of HIV-RNA and/or in the efficiency of provirus transcription. DEAD helicases are generally thought to participate in many aspects of RNA metabolism including RNA transcription, mRNA export, translation and RNA stability. It is now well established that HIV-1 has the ability to use more than one cellular RNA helicases for its replicative life cycle (for a recent review see [23]). The other immediate neighbour gene of SNP rs6503919 is YPEL2, which is a member of the zinc-binding protein family. Besides the fact that it is associated with the mitotic apparatus, details of the exact functions of YPEL2 are not well known to date. It is possible that structural variants of YPEL2 affect the rate of division of immune competent cells, thus, limiting expansion of latently infected cells and their spreading to lymphoid tissues.
###end p 41
###begin p 42
###xml 295 299 295 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Bobardt1">[25]</xref>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Bobardt2">[26]</xref>
###xml 148 151 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 170 173 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 245 248 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 407 410 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 452 455 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 552 555 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 651 654 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 721 724 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 778 781 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 833 836 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 942 945 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We also report an association signal on chromosome 8 for the rs2575735 SNP lying within the Syndecan 2 gene. The role of Syndecans (which are trans HIV receptors) on the HIV reservoir has not been investigated to date. Syndecans play a role for HIV dissemination to T lymphocytes and macrophages[25], [26]. Our findings support the idea that structural variants of Syndecans may be important in controlling HIV spreading and early establishment of the HIV reservoir. It should be noted that the protective variant was not over-represented in long-term HIV controllers, suggesting either a temporal effect or a lack of power due to the small number of HIV controllers tested. It is also important to keep in mind that the HIV controllers in the present study were selected on an HIV-RNA based phenotype (<400 copies/ml) but not on an HIV-DNA based phenotype. Further studies are necessary to confirm the role of Syndecan 2 genetic variants on HIV reservoirs.
###end p 42
###begin p 43
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Hao1">[28]</xref>
###xml 122 125 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 143 146 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 308 313 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 594 597 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 768 773 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 920 923 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 969 972 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Taken together our data provide evidence that four major SNPs in the MHC locus are associated with both control of plasma HIV-RNA and cellular HIV-DNA levels. Most importantly they are associated with viral load replication at the time of primary infection, at the viral set point but also at late stages of HIV-1 disease. It is worth noting that here we performed the genotyping using an Illumina 317K chip and that gains in terms of genetic coverage and transferability could be obtained using more recent technologies [28]. In our study, we provide evidence that the host genetic control on HIV-RNA over time is under the control of both MHC class I and class III genes. Finally, this is the first GWA study which investigated the host determinants controlling the HIV-1 reservoir and identified two new loci in different chromosomes; this result implies that additional and/or different genes than those controlling HIV replication control the establishment of the HIV reservoir.
###end p 43
###begin title 44
Materials and Methods
###end title 44
###begin title 45
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 45
###begin p 46
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Desquilbet1">[11]</xref>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
###xml 101 106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 411 414 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 959 967 <span type="species:ncbi:9606">Patients</span>
###xml 1140 1143 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Since November 1996, the ongoing French ANRS PRIMO CO 06 Cohort has enrolled patients during primary HIV-1 infection in 81 French hospitals[11]. The present study was approved by the Paris Cochin Ethics Committee. All subjects gave their informed written consent. Recent infection was confirmed by one of the following: an incomplete Western Blot pattern (absence of anti-p68 and anti p34); a detectable plasma HIV-RNA or positive p24 antigenemia a negative or weakly reactive ELISA test; an interval less than 6 months between an authenticated negative and a positive ELISA test. The date of infection was estimated on the basis of one of the following: the date of symptom onset minus 15 days, the date of the incomplete Western Blot minus one month, or the mid-point between a negative and a positive ELISA test. The interval between the estimated date of infection and enrolment did not exceed 6 months (median observed interval in the cohort = 46 days). Patients had to be antiretroviral-naive at enrolment. Clinical and biological examinations were conducted at enrolment and at each follow-up visit, and included CD4 cell and plasma HIV-RNA assays. Blood cells and plasma were drawn at enrolment and at follow-up visits and frozen until analyses.
###end p 46
###begin p 47
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 123 126 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 175 183 <span type="species:ncbi:9606">patients</span>
A total of 605 Caucasian patients were selected and genotyped on the ANRS Platform; in 590 of these patients intracellular HIV-DNA levels at enrolment were also measured. The patients were predominantly (87.8%) males and predominantly (96.0%) infected through sexual contact; their median age at enrolment was 34 years (IQR: 29-41).
###end p 47
###begin p 48
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Lambotte1">[13]</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Goujard1">[41]</xref>
###xml 64 67 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 183 186 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 324 332 <span type="species:ncbi:9606">Patients</span>
###xml 572 575 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 587 595 <span type="species:ncbi:9606">patients</span>
Since May 2006, the ongoing French ANRS EP36 study has enrolled HIV controllers, defined as patients who had more than 90% of their viral loads <400 copies/ml after 10 years of known HIV infection, and were disease symptom-free and antiretroviral-therapy free. This study was approved by the Paris Bicetre Ethics Committee. Patients were identified in hospitals throughout France, and were enrolled after written informed consent[13], [41]. At enrolment, 10 ml of whole blood were collected and frozen for further virological and genetic analyses. A total of 45 Caucasian HIV controller patients with available DNA samples were selected for this study.
###end p 48
###begin title 49
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 12 15 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-RNA and HIV-DNA measurements
###end title 49
###begin p 50
###xml 409 412 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Rouzioux1">[8]</xref>
###xml 532 536 532 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-SaezCirion1">[42]</xref>
###xml 7 10 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 26 29 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 91 98 <span type="species:ncbi:9606">patient</span>
###xml 166 169 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 299 302 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 311 314 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 385 388 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 414 417 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 500 503 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Plasma HIV-RNA levels and HIV-DNA in PBMCs used in this paper were quantified in the first patient samples drawn at the time of enrolment in the PRIMO cohort and the HIV controllers study, prior to any antiretroviral therapy initiation. Median time from infection to enrolment was 47 days IQR 37-69 HIV-RNA and HIV-DNA levels measured during the 0-6 months following infection predict HIV disease progression [8]. HIV-RNA levels measured at the time of primary infection are strongly associated with HIV-RNA levels at the set point [42].
###end p 50
###begin p 51
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Kelley1">[43]</xref>
###xml 648 650 644 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 18 21 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 96 99 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 228 233 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 375 378 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 417 420 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 490 493 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Quantification of HIV-RNA in plasma was performed on site at the participating hospitals, while HIV-DNA quantification was performed at the Necker Virology laboratory using real time PCR technology based on amplification of the HIV-1 LTR gene[43]. Briefly, after nucleic acid extraction, the total amount of DNA was quantified. The 95% detection threshold of the assay was 5 HIV-DNA copies/PCR, that is, 70 copies of HIV-DNA per million PBMC when using 0.5 microg of total DNA per PCR. For HIV controller samples, quadruplicate tests were conducted by PCR in order to get numerical data values for very low levels. Results were expressed as the log10 copies number per million PBMC.
###end p 51
###begin title 52
Illumina SNP genotyping and quality-control filtering
###end title 52
###begin p 53
###xml 25 33 <span type="species:ncbi:9606">patients</span>
The DNA samples from all patients were genotyped with Illumina HapMap300 Beadarrays containing 317,000 SNPs. The scanned images were processed using BeadStudio (version 3.2.23) and all genotypes were called using the Illumina proprietary algorithm with genotype clusters generated from the series of samples tested.
###end p 53
###begin p 54
###xml 162 164 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
Samples with call rate below 97% were discarded and SNPs with Gene Call<90% were removed. SNP with either a minor allele frequency below 0.01 or significant (p<10-7) deviation from Hardy-Weinberg equilibrium were excluded. After applying these filters, the average call rate across these samples was 98.3% with 308,222 SNPs on the autosomal chromosomes.
###end p 54
###begin title 55
Statistical analysis
###end title 55
###begin title 56
Population stratification
###end title 56
###begin p 57
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Viard1">[44]</xref>
To detect, and control, possible population stratification, we employed the genomic control approach[44] using all SNPs to estimate the genomic-control inflation factor lambda.
###end p 57
###begin p 58
The value for lambda was small (lambda = 1.005) indicating no population substructure in our cohort and inducing no inflation of the test statistics under the null hypothesis. We, therefore, reported all our analyses results without regard to specific treatment for population structure.
###end p 58
###begin title 59
Multiple testing
###end title 59
###begin p 60
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Benjamini1">[12]</xref>
###xml 179 187 179 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q-values</italic>
###xml 373 381 373 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">q-values</italic>
###xml 425 431 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Devlin1">[45]</xref>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Dalmasso1">[46]</xref>
To address the multiple testing problem, we selected SNPs considering a 25% level for the FDR which is the expected proportion of false discoveries among all discoveries[12]. The q-values, which are analogous to the adjusted P-values for the FDR criterion, measure the minimum FDR that is incurred when calling that test significant. In the present study, we estimated the q-values using the procedure introduced by Dalmasso et al.[45] and considering a stratified approach (by chromosome) as proposed by Sun et al[46].
###end p 60
###begin title 61
###xml 29 32 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Comparison between PRIMO and HIV controller patients
###end title 61
###begin p 62
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Sun1">[47]</xref>
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
We compared allele frequencies between the PRIMO and HIV controller patients using an algorithm dedicated to association studies using bi-allelic markers and allowing fast computation of unbiased exact P-values[47].
###end p 62
###begin title 63
Assessment of linkage disequilibrium between SNPs
###end title 63
###begin p 64
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Guedj1">[48]</xref>
To assess the level of linkage disequilibrium between SNPs, we calculated the pairwise r2 measure between consecutive pairs of markers throughout the genome using the expectation-maximization algorithm to estimate 2-locus haplotype frequencies which is implemented in the R package snpMatrix [48].
###end p 64
###begin title 65
Genome wide association tests
###end title 65
###begin p 66
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003907-Clayton1">[49]</xref>
###xml 46 49 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 58 61 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 281 284 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 292 295 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We tested for an association between SNPs and HIV-RNA and HIV-DNA levels according to a linear model with an additive genetic effect with adjustment for gender. Significance was determined using generalized score tests [49] with SNP genotypes as the dependent variables and either HIV-DNA or HIV-RNA levels as the independent variables.
###end p 66
###begin title 67
Supporting Information
###end title 67
###begin p 68
Upper box: An ideogram depicting chromosome 6 and the annotated region (transparent red rectangle). Middle box: show the SNPs with their associated -log10(P)-values, these lines are spaced according to their actual physical location. Positions of the four SNPs (rs2395029, rs13199524, rs12198173 and rs3093662) are indicated on the figure. Lower box: Linkage disequilibrium data matrix is based on HapMap CEU data. The figure has been constructed using WGAViewer software (, Ge D, Zhang K, Need AC, Martin O, Fellay J, Urban TJ, Telenti A, Goldstein DB. WGAViewer: software for genomic annotation of whole genome association studies.Genome Res. 2008, 18:640-643).
###end p 68
###begin p 69
(0.54 MB TIF)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
###xml 526 531 <span type="species:ncbi:9606">human</span>
Upper box shows the SNPs with their associated -log10(P)-values, these lines are spaced according to their actual physical location. Positions of the four SNPs (rs2395029, rs13199524, rs12198173 and rs3093662) are indicated on the figure. Lower box shows the position of the UCSC known Genes (June, 05 and based on UniProt, RefSeq, and GenBank mRNA) located in the annotated region. The figure has been constructed using Genome Browser software, Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. The human genome browser at UCSC. Genome Res. 2002,12: 996-1006).
###end p 71
###begin p 72
(0.42 MB TIF)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 177 185 <span type="species:ncbi:9606">patients</span>
We wish to thank R. Bizios, C. Bourgain and D. Mc Ilroy for their critical reading of the manuscript, A. Persoz, F. Robergeau and L. Tran for information system assistance, all patients and participating physicians.
###end p 74
###begin title 75
References
###end title 75
###begin article-title 76
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 132 139 <span type="species:ncbi:9606">patient</span>
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.
###end article-title 76
###begin article-title 77
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
###end article-title 77
###begin article-title 78
###xml 60 65 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.
###end article-title 78
###begin article-title 79
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A whole-genome association study of major determinants for host control of HIV-1.
###end article-title 79
###begin article-title 80
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
###end article-title 80
###begin article-title 81
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection. The SEROCO Study Group.
###end article-title 81
###begin article-title 82
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
###end article-title 82
###begin article-title 83
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 119 124 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts.
###end article-title 83
###begin article-title 84
###xml 16 51 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.
###end article-title 84
###begin article-title 85
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Identification of host proteins required for HIV infection through a functional genomic screen.
###end article-title 85
###begin article-title 86
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Does transient HAART during primary HIV-1 infection lower the virological set-point?
###end article-title 86
###begin article-title 87
Controlling the false discovery rate:a practical and powerful approach to multiple testing.
###end article-title 87
###begin article-title 88
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 55 63 <span type="species:ncbi:9606">patients</span>
HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.
###end article-title 88
###begin article-title 89
Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome.
###end article-title 89
###begin article-title 90
###xml 102 109 <span type="species:ncbi:9606">patient</span>
The molecular basis of complete complement C4A and C4B deficiencies in a systemic lupus erythematosus patient with homozygous C4A and C4B mutant genes.
###end article-title 90
###begin article-title 91
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 114 119 <span type="species:ncbi:9606">human</span>
The gene encoding TBC1D1 with homology to the tre-2/USP6 oncogene, BUB2, and cdc16 maps to mouse chromosome 5 and human chromosome 4.
###end article-title 91
###begin article-title 92
Mammalian SP/KLF transcription factors: bring in the family.
###end article-title 92
###begin article-title 93
Basic Kruppel-like factor functions within a network of interacting haematopoietic transcription factors.
###end article-title 93
###begin article-title 94
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 28 31 <span type="species:ncbi:10116">rat</span>
hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG.
###end article-title 94
###begin article-title 95
###xml 25 30 <span type="species:ncbi:9606">human</span>
An intronless homolog of human proto-oncogene hPTTG is expressed in pituitary tumors: evidence for hPTTG family.
###end article-title 95
###begin article-title 96
###xml 106 109 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
###end article-title 96
###begin article-title 97
###xml 26 31 <span type="species:ncbi:9606">human</span>
Identification of a novel human DDX40gene, a new member of the DEAH-box protein family.
###end article-title 97
###begin article-title 98
###xml 25 30 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Role of RNA helicases in HIV-1 replication.
###end article-title 98
###begin article-title 99
Identification and characterization of a novel gene family YPEL in a wide spectrum of eukaryotic species.
###end article-title 99
###begin article-title 100
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
###end article-title 100
###begin article-title 101
###xml 43 46 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Syndecan captures, protects, and transmits HIV to T lymphocytes.
###end article-title 101
###begin article-title 102
###xml 9 14 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy.
###end article-title 102
###begin article-title 103
Calibrating the performance of SNP arrays for whole-genome association studies.
###end article-title 103
###begin article-title 104
###xml 92 97 <span type="species:ncbi:9606">human</span>
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.
###end article-title 104
###begin article-title 105
A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease Loci.
###end article-title 105
###begin article-title 106
###xml 104 132 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals.
###end article-title 106
###begin article-title 107
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.
###end article-title 107
###begin article-title 108
###xml 138 173 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.
###end article-title 108
###begin article-title 109
###xml 26 31 <span type="species:ncbi:9606">human</span>
Allelic repertoire of the human MHC class I MICA gene.
###end article-title 109
###begin article-title 110
###xml 26 31 <span type="species:ncbi:9606">human</span>
Allelic repertoire of the human MICB gene.
###end article-title 110
###begin article-title 111
Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
###end article-title 111
###begin article-title 112
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.
###end article-title 112
###begin article-title 113
###xml 47 82 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages.
###end article-title 113
###begin article-title 114
###xml 8 13 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
###end article-title 114
###begin article-title 115
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
###end article-title 115
###begin article-title 116
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 97 100 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients.
###end article-title 116
###begin article-title 117
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 63 66 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.
###end article-title 117
###begin article-title 118
###xml 79 82 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The relation between symptoms, viral load, and viral load set point in primary HIV infection.
###end article-title 118
###begin article-title 119
###xml 101 106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level.
###end article-title 119
###begin article-title 120
Genomic control for association studies.
###end article-title 120
###begin article-title 121
A simple procedure for estimating the false discovery rate.
###end article-title 121
###begin article-title 122
Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies.
###end article-title 122
###begin article-title 123
A fast, unbiased and exact allelic test for case-control association studies.
###end article-title 123
###begin article-title 124
An R package for analysis of whole-genome association studies.
###end article-title 124
###begin article-title 125
On generalized score test.
###end article-title 125
###begin p 126
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 126
###begin p 127
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was funded by the ANRS 101 Rue de Tolbiac 75013 Paris FRANCE.
###end p 127

